• Major banks including JPMorgan, Citigroup, and Barclays cut price targets on dozens of stocks.
  • Cuts span technology, industrials, consumer, and healthcare names, signaling broad analyst caution.
  • Multiple firms lowered targets on stocks like $CSGP, $SWKS, and $UPS, reflecting macro and sector-headwinds.

A Wave of Revisions

Wall Street analysts unleashed a flurry of price-target cuts on Thursday, with JPMorgan, Citigroup, Barclays, RBC, and several other firms reducing their outlooks on a wide array of stocks. The cuts affected high-profile names such as $BE, $BA, $DIS, and $SPGI, with many targets slashed by double-digit percentages. According to people familiar with the matter, the revisions stem from a combination of macroeconomic uncertainty, rising interest rates, and company-specific headwinds.

JPMorgan alone cut targets on nearly a dozen stocks, including $CHTR to $150 from $200, $LEU to $178 from $236, and $CSGP to $52 from $58. Barclays reduced its price target on $GILD to $145 from $155 and on $VRNS to $50 from $52. Citigroup trimmed targets on $GLW to $220 from $240, $DIS to $135 from $145, and $QRVO to $95 from $100. Other banks followed suit: RBC cut $BA to $265 from $275; KBW lowered $CSGP to $29 from $41; and Susquehanna cut $KLAC to $215 from $275.

Sector-Wide Caution

The breadth of the cuts indicates a broader reassessment of equity valuations amid persistent inflation and tightening financial conditions. "Analysts are recalibrating their models to reflect a higher cost of capital and slower growth," said one portfolio manager who asked not to be named. The technology sector was particularly hard hit, with firms like $SWKS and $QRVO seeing multiple downgrades. $SWKS received cuts from Citigroup, JPMorgan, RBC, and TD Cowen, with targets ranging from $64 to $70. Similarly, $KLAC saw targets slashed by Deutsche Bank and Susquehanna.

Industrial and consumer names also suffered. $UPS saw cuts from Bernstein, JPMorgan, and Stephens, with targets now between $115 and $133. $HLT was trimmed by Jefferies to $394 from $397. The cuts come as companies face margin pressure from input costs and a potential slowdown in demand.

Implications and Outlook

While price-target cuts do not always signal an imminent sell-off, the coordinated nature of these revisions suggests a shift in analyst sentiment. "When multiple firms lower targets on the same stock, it often reflects a consensus view that the risk-reward has deteriorated," noted a market strategist. However, some analysts remain selectively bullish, with a few targets still above current trading levels. Investors will be watching for earnings reports and guidance updates in the coming weeks to confirm or challenge these revised outlooks.

Correction: An earlier version of this article misstated the number of stocks with cuts from JPMorgan; it has been corrected to reflect the full list.